Searched for
ALTERNATIVES TO PAINKILLERS
Pharma exporters seek freight sops and logistical support as costs riseAs tensions in West Asia escalate, Indian pharmaceutical exporters are grappling with surging costs. In response, Pharmexcil is advocating ...- Nimesulide banned: Govt puts a stop to manufacture, sale of all oral formulations containing the popular painkiller above 100 mgNimesulide sale banned: The move follows recommendation by India’s top research body- Indian Council of Medical Research (ICMR). In it’s ea...
- Cannabis stocks surge on report Trump seeks to ease restrictionsShares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to push the govern...
- From antibiotics to multivitamins: Apollo doctor explains 10 medicine habits could be silently harming youA Hyderabad neurologist highlighted ten common medical practices lacking scientific backing, often prescribed despite weak evidence. These ...
- From unicorn horns to IBC forms: Time to avoid the great Indian startup hangoverIndia's startup dream faces a reality check as many ventures falter. The article presents nine crucial questions to evaluate business model...
- Arthritis pain relief with black cumin? What research says about this ancient remedyA recent study highlighted by TOI reveals that black cumin seed oil (Nigella sativa) offers a natural and effective way to alleviate arthri...
- Government bans popular painkiller to save vulturesThe Centre has banned the manufacture, sale, and distribution of Nimesulide due to its toxicity to vultures. Studies showed that the drug c...
- Startups positioning India for exponential economic growth: Zupee founder Dilsher MalhiAt the India Internet Governance Forum 2024, Zupee CEO Dilsher Malhi highlighted startups' role in India's economic growth, driven by digit...
- Rajputana Biodiesel shares debut at 90% premium over IPO price on NSE SME platformShares of Rajputana Biodiesel debuted at a 90% premium, listing on the NSE SME platform at Rs 247. The Rs 25 crore IPO saw immense interest...
- Government advisory alerts users about Meftal's risks: Here's everything you need to know about itThe Indian Pharmacopoeia Commission's advisory alerts users about Meftal's dangers, specifically its active ingredient mefenamic acid, link...
- Now, you will need a prescription for buying aspirin, ibuprofen, diclofinac in Delhi. Read whyDelhi government has asked chemists to restrain from selling aspirin, ibuprofen and diclofenac without a valid doctor's prescription to add...
- Not just allopathy: Now parents prefer homoeopathy, ayurveda and acupuncture to heal their petsPet parents are increasingly gravitating towards alternative medicine, reiki, and home remedies.
- Suffering from chronic pain? Acupuncture might be a safe alternative for drugsAcupuncture is a form of alternative medicine in which thin needles are inserted into the body.
- Government ban on 350 drugs jolts 4% of pharma retail marketPfizer and Abbott and domestic companies including Alkem, Ipca and MacLeods, and is likely to be contested by companies, sources say.
- Six ways to cure a throbbing headacheHaving a headache? Popped a pill? Consider these six alternatives that will help you keep headaches at bay.
- Health ministry bans two drugs Analgin and Pioglitazone; industry protestsThe health ministry has suspended the sale of two drugs - painkiller Analgin and anti-diabetes drug Pioglitazone and all its combinations.
- Gvernment bans sale of painkillerThe government has banned the sale of pain-relieving medicine, dextropropoxyphene, in a move that is expected to impact pharma companies' b...
- For cheaper drug options, send SMSYou would soon be able to find the most affordable alternative to the medicine prescribed by your doctor through an SMS-based service.
- Philippines orders Novartis to pull anti-arthritis drugPhilippine health regulators on Friday ordered Swiss pharmaceutical giant Novartis to pull the painkiller Lumiracoxib from the market amid ...
- Merck's Vioxx successor equally risky, finds studyMerck & Co’s experimental painkiller, Arcoxia, may carry the same risk of heart attacks and strokes as Vioxx, according to an analysis of 2...
Load More
